|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities-held-to-maturity, at amortized cost net of allowance for credit losses of $60 and $73 at June 30, 2026 and December 31, 2025, respectively, (fair value $327,158 and $344,576 at June 30, 2026, and December 31, 2025, respectively) | ||||||||||||||||||||
| Fixed maturity securities-available-for-sale, at fair value (amortized cost $290,264, allowance for credit losses of $0 at June 30, 2026 and amortized cost $317,116, allowance for credit losses of $0 at December 31, 2025) | ||||||||||||||||||||
| Equity securities, at fair value (cost $31,164 and $31,165 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Amounts recoverable from reinsurers (net of allowance for credit losses of $217 and $264 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Premiums receivable (net of allowance for credit losses of $4,159 and $4,172 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Federal income tax recoverable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and shareholders’ equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Reserves for loss and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Amounts held for others | ||||||||||||||||||||
| Policyholder deposits | ||||||||||||||||||||
| Insurance-related assessments | ||||||||||||||||||||
| Federal income tax payable | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Payable for investments purchased | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock: voting-$0.01 par value authorized shares-50,000,000 in 2026 and 2025; 20,814,250 and 20,769,021 shares issued; and 18,536,058 and 18,794,881 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost (2,278,192 and 1,974,140 shares at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
